Haleon (HLN) Non Operating Income (2021 - 2023)
Haleon (HLN) posted Non Operating Income of -$333.9 million for Q4 2023, down 177.92% on a QoQ basis from -$120.1 million in Q2 2023, and down 158.77% year-over-year from $568.1 million in Q4 2022.
Haleon (HLN) Non Operating Income (2021 - 2023) Analysis & Trends
Haleon's Non Operating Income history runs 3 years deep, the most recent figure standing at -$333.9 million for Q4 2023.
- Quarterly Non Operating Income fell 158.77% year-over-year to -$333.9 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was -$687.0 million (changed N/A YoY) and the FY2025 annual result came in at -$345.4 million, up 10.51% from the prior year.
- Non Operating Income was -$333.9 million for Q4 2023 at Haleon, down from -$120.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at -$1.3 million in Q4 2021 and bottomed at -$333.9 million in Q4 2023.
- A 3-year average of -$122.1 million and a median of -$112.0 million in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income slumped 9471.3% — and 2023, when it sank 158.77%.
- Haleon's Non Operating Income stood at -$1.3 million in 2021, then slumped by 9471.3% to -$129.0 million in 2022, then slumped by 158.77% to -$333.9 million in 2023.
- Business Quant data shows HLN's Non Operating Income at -$333.9 million in Q4 2023, -$120.1 million in Q2 2023, and -$103.9 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | -216.00 Mn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | 20.00 Mn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -7.50 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | 53.40 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | -13.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -333.87 Mn |
| Jun 30, 2023 | -120.13 Mn |
| May 3, 2023 | -103.94 Mn |
| Dec 31, 2022 | -129.02 Mn |
| Sep 20, 2022 | -44.33 Mn |
| Dec 31, 2021 | -1.35 Mn |